Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "Shionogi"

Viiv Healthcare launches Triumeq in Japan
Pharma Letter

GSK reins in drug sell off

GLAXOSMITHKLINE has dropped plans to float its HIV drug business. ViiV, its joint venture with Pfizer and Japan's Shionogi, could have been valued at about £15billion but Glaxo said its decision to retain the business reflects its strong positive ... Scottish Daily Express, 3 weeks ago
GSK Cuts Return to Holders From Novartis Asset Swap Morningstar.com, 3 weeks ago
Viiv Healthcare launches Triumeq in Japan Pharma Letter, 1 month ago
[x]  

Naldemedine shows promise in treating OIC in patients with chronic non-cancer pain.

Shionogi Inc. today announced data from a Phase IIb study that showed 0.2 mg and 0.4 mg of naldemedine demonstrated statistically significant efficacy in treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain.
 News-Medical.Net1 week ago Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation  PR Newswire1 week ago Shionogi, Inc. Release: Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation 5/19/2015  ClinicSpace1 week ago Shionogi's Phase III OIC study meets primary and secondary endpoints  Individual.com1 month ago
[x]  

Shionogi receives approval for house dust mite immunotherapy tablet in Japan

STALLERGENES S.A., a biopharmaceutical company, has announced that its partner, Shionogi & Co., Ltd has received the approval from the Japanese health authorities, Pharmaceuticals and Medical Devices Agency, or PMDA, for STG320, a immunotherapy ...
 Individual.com1 month ago
Wall Street Business Network

Filing triggers $10M payment for Egalet

Egalet Corp. received a $10 million milestone payment from Japanese pharmaceutical company Shionogi under terms of a licensing agreement the two organizations signed in 2013. The payment was triggered by Shionogi filing an investigational new drug ...
 Philadelphia Business Journal2 months ago Egalet Earns $10 Million Milestone Payment Triggered by Advancement of Shionogi's Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's Guardian Technology  Wall Street Business Network2 months ago Egalet : Earns $10 Million Milestone Payment Triggered by Advancement of Shionogi's Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's Guardian Technology  4 Traders2 months ago Egalet announces business highlights, financial results for first quarter 2015  News-Medical.Net3 weeks ago
[x]  

Shionogi : Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of...

Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist] By a News Reporter-Staff ...
 4 Traders1 week ago SHIONOGI : Data on Pharmacokinetics Reported by Researchers at Shionogi & Co. Ltd. (Using Improved Serial Blood Sampling Method of Mice to Study...  4 Traders2 months ago

Aurobindo Pharma seeks US FDA tentative approval for generic dolutegravir to treat HIV

ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced that Aurobindo Pharma, a Rs. 8,000 crore Indian pharma major, has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for ...
 PharmaBiz2 days ago ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV  National AIDS Treatment Advocacy Project1 hour ago Nouvelle étape pour la collaboration entre ViiV Healthcare et la CHAI avec le premier dépôt de dossier auprès de la FDA par Aurobindo Pharma pour le dolutégravir générique pour le traitement du VIH  Africa News Wire3 days ago ViiV Healthcare And Collaboration Delivers Second Milestone With First Filing With The FDA Of Generic Dolutegravir By Aurobindo Pharma For The Treatment Of HIV  BioSpace3 days ago
[x]  
RTTNews.com

Asian Markets Mostly Lower On Wall Street Cues

Asian stock markets are mostly in negative territory on Wednesday, tracking the weak lead overnight from Wall Street as upbeat U.S. economic data overnight spurred concerns of an interest rate hike sooner rather than later. Additionally, a stronger ...
 RTTNews.com3 days ago Asian Markets Mostly Higher  London South East1 month ago

Japanese Market Marginally Lower

The Japanese stock market is marginally lower on Wednesday, following the negative cues overnight from Wall Street and as investors resorted to profit taking after eight straight days of gains. In late-morning trades, the benchmark Nikkei 225 Index ...
 RTTNews.com3 days ago Japanese Market Drifts Lower In Choppy Trade  RTTNews.com1 month ago
Investing.com

Japan stocks higher at close of trade; Nikkei 225 up 0.12%

Japan stocks were higher after the close on Tuesday, as gains in the Transport, Paper & Pulp and Fishery sectors led shares higher. At the close in Tokyo, the Nikkei 225 rose 0.12% to hit a new all time high. The best performers of the session ...
 Investing.com3 days ago Japanese Stocks Swing as Energy Shares Rise, Drug Makers Drop  La Repubblica1 month ago Japanese Stocks Fall as Yen Strengthens After U.S. Retail Sales  La Repubblica1 month ago

Resistant E coli Colonization Not Rare in Healthy Families

Healthy mothers and children are frequently colonized with pathogenic Escherichia coli that are resistant to ciprofloxacin as well as multiple additional antibiotics, researchers have found. The identified strain of E coli was similar to human ...
 Dermatology Online Journal4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less